FDA Drug recall D-0397-2026
MR. 7 SUPER 700000 capsules, 1 capsule blister card, Distributed by mR. 7
- FDA Drug
- Class I
- ongoing
- Published 2026-03-11
On 2026-03-11 the FDA classified a Class I recall of MR. 7 SUPER 700000 capsules, 1 capsule blister card, Distributed by mR. 7 by Stuffbynainax, citing marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared sildenafil and tadalafil.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0397-2026 |
| Classification | Class I |
| Status | ongoing |
| Initiated | 2025-12-15 |
| Published | 2026-03-11 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Stuffbynainax |
| Distribution | n/a |
Product
MR. 7 SUPER 700000 capsules, 1 capsule blister card, Distributed by mR. 7
Reason
Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared sildenafil and tadalafil
Identifiers
| code_info | All codes; Exp 12/31/2029 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0397-2026%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.